Francesco Bianchi Sells 3,500 Shares of LivaNova (NASDAQ:LIVN) Stock

LivaNova PLC (NASDAQ:LIVN) Director Francesco Bianchi sold 3,500 shares of LivaNova stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $78.01, for a total value of $273,035.00. Following the sale, the director owned 4,434 shares in the company, valued at $345,896.34. The trade was a 44.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Francesco Bianchi also recently made the following trade(s):

• On Monday, August 31st, Francesco Bianchi sold 1,650 shares of LivaNova stock. The stock was sold at an average price of $79.72, for a total transaction of $131,538.00.

LivaNova Price Performance

LIVN opened at $79.47 on Wednesday. LivaNova PLC has a fifty-two week low of $48.82 and a fifty-two week high of $85.76. The firm has a 50-day moving average of $80.20 and a 200 day moving average of $73.50. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.45. The firm has a market cap of $4.38 billion, a P/E ratio of 23.51 and a beta of 0.87.

LivaNova (NASDAQ:LIVN) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.09 by $0.17. LivaNova had a net margin of 12.82% and a return on equity of 16.35%. The business had revenue of $390.59 million for the quarter, compared to analyst estimates of $380.50 million. During the same quarter in the previous year, the firm posted $1.05 earnings per share. The company’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, research analysts expect that LivaNova PLC will post 3.77 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on LIVN shares. Weiss Ratings raised LivaNova from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 18th. Piper Sandler reaffirmed an “overweight” rating and set a $90.00 price objective (up from $87.00) on shares of LivaNova in a report on Wednesday, September 2nd. Freedom Capital upgraded shares of LivaNova to a “hold” rating in a research note on Tuesday, June 30th. Mizuho boosted their price target on shares of LivaNova from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th. Finally, Needham & Company LLC raised their price objective on shares of LivaNova from $81.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Six analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $84.12.

Institutional Investors Weigh In On LivaNova

A number of institutional investors and hedge funds have recently modified their holdings of LIVN. Millennium Management LLC grew its stake in LivaNova by 17.3% during the fourth quarter. Millennium Management LLC now owns 3,484,082 shares of the company’s stock valued at $214,376,000 after acquiring an additional 514,268 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in LivaNova by 2.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,826,248 shares of the company’s stock valued at $116,067,000 after purchasing an additional 38,320 shares during the period. Geode Capital Management LLC grew its position in shares of LivaNova by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 1,458,838 shares of the company’s stock valued at $89,775,000 after purchasing an additional 12,750 shares in the last quarter. LSV Asset Management grew its position in shares of LivaNova by 2.7% during the 4th quarter. LSV Asset Management now owns 693,110 shares of the company’s stock valued at $42,647,000 after purchasing an additional 18,500 shares in the last quarter. Finally, Janus Henderson Group PLC increased its holdings in shares of LivaNova by 1,978.8% in the first quarter. Janus Henderson Group PLC now owns 471,379 shares of the company’s stock worth $29,961,000 after purchasing an additional 448,703 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

About LivaNova

LivaNova PLC (NASDAQ: LIVN) is a medical device company that develops and manufactures technologies for the treatment of neurological and cardiovascular conditions. The company serves hospitals, physicians and patients in markets around the world, with operations and commercial activities spanning North America, Europe and other international markets.

LivaNova’s Neuromodulation business produces vagus nerve stimulation (VNS) systems marketed under the VNS Therapy brand. These implantable devices are used as an adjunctive treatment for drug-resistant epilepsy and are designed to deliver programmed electrical stimulation to the vagus nerve.